Designed for in vitro diagnostic use, the Atellica CH Glucose Hexokinase 3 (GluH_3) assay accurately quantifies glucose levels in human serum, cerebrospinal fluid (CSF), plasma (including lithium heparin, potassium EDTA, sodium fluoride/potassium oxalate), and urine.
Essential for diagnosing and managing carbohydrate metabolism disorders such as diabetes mellitus, neonatal hypoglycemia, idiopathic hypoglycemia, and insulin overdose, ensuring comprehensive patient care.
Compatible with the Atellica CH Analyzer, the reagent supports a high throughput of 6,240 tests, optimizing laboratory efficiency and productivity.
